Antiviral properties of lactoferrin\-a natural immunity molecule

Molecules

Volumn 16, Issue 8, 2011, Pages 6992-7012

  Berlutti, Francesca ^a   Pantanella, Fabrizio ^a   Natalizi, Tiziana ^a   Frioni, Alessandra ^a   Paesano, Rosalba ^b   Polimeni, Antonella ^b   Valenti, Piera ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Lactoferrin; Viral infection; Virus

Indexed keywords

ANTIVIRUS AGENT; HEPARAN SULFATE; IRON CHELATING AGENT; LACTOFERRIN;

ANIMAL; ARTICLE; BINDING SITE; CAT; CATTLE; CHEMICAL STRUCTURE; DRUG EFFECT; FEMALE; GROWTH, DEVELOPMENT AND AGING; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MOUSE; PROTEIN BINDING; RAT; VIROLOGY; VIRUS; VIRUS ENTRY; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; ANTIVIRAL AGENTS; BINDING SITES; CATS; CATTLE; FEMALE; HEPARITIN SULFATE; HUMANS; IMMUNITY, INNATE; IRON CHELATING AGENTS; LACTOFERRIN; MICE; MODELS, MOLECULAR; PROTEIN BINDING; RATS; VIRUS DISEASES; VIRUS INTERNALIZATION; VIRUS REPLICATION; VIRUSES;

EID: 80052256989     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules16086992     Document Type: Article

References (152)

1. Soerensen, M.; Soerensen, S.P.L. The proteins in whey. C. R. Trav. Lab. Carlsberg. 1939, 23, 55-99.
2. Johansson, B. Isolation of an iron-containing red protein from human milk. Acta Chem. Scand. 1960, 14, 510-512.
3. Montreuil, J.; Tonnelat, J.; Mullet, S. Preparation and properties of lactosiderophilin (lactotransferrin) of human milk. Biochim. Biophys. Acta 1960, 45, 413-421.
4. Groves, M.L. The isolation of a red protein from milk. J. Am. Chem. Soc. 1960, 82, 3345-3350.
5. Mazurier, J.; Spik, G. Comparative study of the iron-binding properties of human transferrins. I. Complete and sequential iron saturation and desaturation of the lactotransferrin. Biochim. Biophys. Acta 1980, 629, 399-408. (Pubitemid 10090979)
6. Baker, E.N. Structure and reactivity of transferrins. Adv. Inorg. Chem. 1994, 41, 389-463.
7. Anderson, B.F.; Baker, H.M.; Dodson, E.J.; Norris, G.E.; Rumball, S.V.; Waters, J.M.; Baker, E.N. Structure of human lactoferrin at 3.2-A resolution. Proc. Natl. Acad. Sci. USA 1987, 84, 1769-1773. (Pubitemid 17054094)
8. Anderson, B.F.; Baker, H.M.; Norris, G.E.; Rice, D.W.; Baker, E.N. Structure of human lactoferrin: Crystallographic structure analysis and refinement at 2.8 A resolution. J. Mol. Biol. 1989, 209, 711-734. (Pubitemid 20046127)
9. Baker, E.N.; Baker, H.M. Molecular structure, binding properties and dynamics of lactoferrin. Cell. Mol. Life Sci. 2005, 62, 2531-2539. (Pubitemid 41721228)
10. Metz-Boutigue, M.-H.; Jolles, J.; Mazurier, J.; Schoentgen, F.; Legran, D.D.; Spik, G.; Montreuil, J.; Jolles, P. Human lactotransferrin: Amino acid sequence and structural comparisons with other transferrins. Eur. J. Biochem.1984, 145, 659-676. (Pubitemid 15178137)
11. Baker, E.N.; Rumball, S.V.; Anderson, B.F. Transferrins: Insights into structure and function from studies on lactoferrin. Trends Biochem. Sci. 1987, 12, 350-353.
12. Bruns, C.M.; Nowalk, A.J.; Arvai, A.S.; McTigue, M.A.; Vaughan, K.G.; Mietzner, T.A.; McRee, D.E. Structure of Haemophilus influenzae Fe(+3)-binding protein reveals convergent evolution within a superfamily. Nat Struct. Biol. 1997, 4, 919-924. (Pubitemid 27479443)
13. Baker, E.N.; Baker, H.M.; Kidd, R.D. Lactoferrin and transferrin: Functional variations on a common structural framework. Biochem. Cell Biol. 2002, 80, 27-34. (Pubitemid 34194225)
14. MacGillivray, R.T.A.; Moore, S.A.; Chen, J.; Anderson, B.F.; Baker, H.; Luo, Y.; Bewley, M.; Smith, C.A.; Murphy, M.E.P.; Wang, Y.; Mason, A.B.; Woodworth, R.C.; et al. Two high-resolution crystal structures of the recombinant N-lobe of human transferrin reveal a structural change implicated in iron release. Biochemistry 1998, 37, 7919-7928. (Pubitemid 28307052)
15. Grossmann, J.G.; Neu, M.; Pantos, E.; Schwab, FJ.; Evans, R.W.; Towns-Andrews, E.; Lindley, P.F.; Appel, H.; Thies, W.G.; Hasnain, S.S. X-ray solution scattering reveals conformational changes upon iron uptake in lactoferrin, serum and ovo-transferrins. J. Mol. Biol. 1992, 225, 811-819.
16. Octave, J.N.; Schneider, Y.J.; Trouet, A.; Crichton, R.R. Iron uptake and utilization by mammalian cells. I: Cellular uptake of transferrin and iron. Trends Biochem. Sci. 1983, 8, 217-220. (Pubitemid 14240729)
17. Day, C.L.; Stowell, K.M.; Baker, E.N.; Tweedie, J.W. Studies of the N-terminal half of human lactoferrin produced from the cloned cDNA demonstrate that interlobe interactions modulate iron release. J. Biol. Chem. 1992, 267, 13857-13862.
18. Ward, P.P.; Zhou, X.; Conneely, O.M. Cooperative interactions between the amino and carboxyl38 terminal lobes contribute to the unique iron-binding stability of lactoferrin. J. Biol. Chem. 1996, 271, 12790-12794. (Pubitemid 26175850)
19. Jameson, G.B.; Anderson, B.F.; Norris, G.E.; Thomas, D.H.; Baker, E.N. Structure of human apolactoferrin at 2.0 A resolution. Refinement and analysis of ligand-induced conformational change. Acta Crystallogr. D. Biol. Crystallogr. 1998, 54, 1319-1335.
20. Valenti, P.; Antonini, G. Lactoferrin: An important host defence againstmicrobial and viral attack. Cell. Mol. Life Sci. 2005, 62, 2576-2587. (Pubitemid 41721231)
21. Kim, S.J.; Yu, D.Y.; Pak, K.W.; Jeong, S.; Kim, S.W.; Lee, K.K. Structure of the human lactoferrin gene and its chromosomal localization. Mol. Cells 1998, 8, 663-668. (Pubitemid 128490245)
22. Schwerin, M.; Solinas Toldo, S.; Eggen, A.; Brunner, R.; Seyfert, H.M.; Fries, R. The bovine lactoferrin gene (LTF) maps to chromosome 22 and syntenic group U12. Mamm. Genome 1994, 5, 486-489. (Pubitemid 2127239)
23. Johnston, J.J.; Rintels, P.; Chung, J.; Sather, J.; Benz, E.J., Jr.; Berliner, N. Lactoferrin gene promoter: Structural integrity and nonexpression in HL60 cells. Blood 1992, 79, 2998-3006.
24. Panella, T.J.; Liu, Y.H.; Huang, A.T.; Teng, C.T. Polymorphism and altered methylation of the lactoferrin gene in normal leukocytes, leukemic cells, and breast cancer. Cancer Res. 1991, 51, 3037-3043.
25. Rado, T.A.; Wei, X.P.; Benz, E.J. Isolation of lactoferrin cDNA from a human myeloid library and expression of mRNA during normal and leukemic myelopoiesis. Blood 1987, 70, 989-993. (Pubitemid 18022373)
26. Seyfert, H.M.; Kuhn, C. Characterization of a first bovine lactoferrin gene variant, based on an EcoRI polymorphism. Anim. Genet. 1994, 25, 54.
27. Teng, C.T. Regulation of lactoferrin gene expression by estrogen and epidermal growth factor: Molecular mechanism. Cell Biochem. Biophys. 1999, 31, 49-64. (Pubitemid 129555675)
28. Masson, P.L.; Heremans, J.F. Lactoferrin in milk from different species. Comp. Biochem. Physiol. 1971, B39, 119-129.
29. Masson, P.L.; Heremans, J.F.; Dive, C. An iron-binding protein common to many external secretions. Clin. Chim. Acta 1966, 14, 735-739.
30. Masson, P.L.; Heremans, J.F.; Schonne, E. Lactoferrin, an iron-binding protein in neutrophilic leukocytes. J. Exp. Med. 1969, 130, 643-658.
31. Dalmastri, C.; Valenti, P.; Visca, P.; Vittorioso, P.; Orsi, N. Enhanced antimicrobial activity of lactoferrin by binding to the bacterial surface. Microbiologica 1988, 11, 225-230.
32. Naidu, A.S.; Anderson, M.; Miedzobrodzki, J.; Forsgren, A. Bovine lactoferrin receptors in Staphylococcus aureus isolated from bovine mastitis. J. Dairy Sci. 1991, 74, 1218-1226.
33. Marchetti, M.; Superti, F. Antiviral activity of lactoferrin. In Recent Developments in Antiviral Research; Pandalai, S.G. Ed.; Transworld Research Network: Trivandrum, India, 2001; pp. 193-203.
34. He, J.; Furmanski, P. Sequence specificity and transcriptional activation in the binding of lactoferrin to DNA. Nature 1995, 373, 721-724.
35. van Berkel, P.H.C.; Geerts, M.E.J.; van Veen, H.A.; Mericskay, M.; de Boer, H.A.; Nuijens, J.H. The N-terminal stretch Arg2 Arg3, Arg4, and Arg5 of human lactoferrin is essential for binding to heparin, bacterial lipopolysaccharide, human lysozyme and DNA. Biochem. J. 1997, 328, 145-151. (Pubitemid 27499451)
36. Mann, D.M.; Romm, E.; Migliorini, M. Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin. J. Biol. Chem. 1994, 269, 23661-23667. (Pubitemid 24293571)
37. Schaible, U.E.; Kaufmann, H.E. Iron and microbial infection. Nat. Rev. Microbiol. 2004, 2, 946-953. (Pubitemid 39562533)
38. Orsi, N. The antimicrobial activity of lactoferrin: Current status and perspectives. Biometals 2004, 17, 189-196. (Pubitemid 38987136)
39. Bullen, J.J.; Rogers, H.J.; Leigh, L. Iron-binding proteins in milk and resistance to Escherichia coli infections in infants. Br. Med. J. 1972, 1, 69-75.
40. Weinberg, E.D. The development of awareness of iron-withholding defense. Perspect. Biol. Med. 1993, 36, 215-221. (Pubitemid 23055082)
41. Ratledge, C.; Dover, L.G. Iron metabolism in pathogenic bacteria. Annu. Rev. Microbiol. 2000, 54, 881-941.
42. Braun, V. Bacterial iron transport related to virulence. Contrib. Microbiol. 2005, 12, 210-233.
43. Ekins, A.; Khan, A.G.; Shouldice, S.R.; Schryvers, A.B. Lactoferrin receptors in Gram-negative bacteria: Insights into the iron acquisition process. Biometals 2004, 17, 235-243. (Pubitemid 38987143)
44. Arnold, R.R.; Cole, M.F.; Mcghee, J.R. A bactericidal effect for human lactoferrin. Science 1977, 197, 263-265. (Pubitemid 8130437)
45. Ellison, R.T., III; Giehl, T.J.; La Force, F.M. Damage of the outer membrane of enteric gram negative bacteria by lactoferrin and transferrin. Infect. Immun. 1988, 56, 2774-2781. (Pubitemid 18259927)
46. Ellison, R.T., III; La Force, M.; Giehl, T.J.; Boose, D.; Dunn, B.E. Lactoferrin and transferring damage of the Gramnegative outer membrane is modulated by Ca++ and Mg++. J. Gen. Microbiol. 1990, 136, 1437-1446. (Pubitemid 20238484)
47. Visca, P.; Dalmastri, C.; Verzili, D.; Antonini, G.; Chiancone, E.; Valenti, P. Interaction of lactoferrin with Escherichia coli cells and correlation with antibacterial activity. Med. Microbiol. Immunol. 1990, 179, 323-333.
48. Appelmelk, B.J.; An, Y.Q.; Geerts, M.; Thijs, B.G.; de Boer, H.A.; MacLaren, D.M.; de Graaff, J.; Nuijens, J.H. Lactoferrin is a lipid A-binding protein. Infect. Immun. 1994, 62, 2628-2632. (Pubitemid 24157102)
49. Brandenburg, K.; Jurgens, G.; Muller, M.; Fukuoka, S.; Koch, M.H.J. Biophysical characterization of lipopolysaccharide and lipid A inactivation by lactoferrin. Biol. Chem. 2001, 382, 1215-1225. (Pubitemid 32894028)
50. Tomita, M.; Bellamy, W.; Takase, M.; Yamauchi, K.; Wakabayashi, K.; Kavase, K. Potent antibacterial peptides generated by pepsin digestion of bovine lactoferrin. J. Dairy Sci. 1991, 74, 4137-4142.
51. Bellamy, W.; Takase, M.; Yamauchi, K.; Wakabayashi, H.; Kawase, K.; Tomita, M. Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta 1992, 1121, 130-136.
52. Bellamy, W.; Takase, M.; Wakabayashi, H.; Kavase, K.; Tomita, M. Antibacterial spectrum of lactoferricin B, a potent bactericide peptide derived from the N-terminal region of bovine lactoferrin. J. Appl. Bacteriol. 1992, 73, 472-479.
53. Rossi, P.; Giansanti, F.; Boffi, A.; Ajello, M.; Valenti, P.; Chiancone, E.; Antonini, G. Ca2+ binding to bovine lactoferrin enhances protein stability and infl uences the release of bacterial lipopolysaccharide. Biochem. Cell Biol. 2002, 80, 41-48. (Pubitemid 34194227)
54. Lu, L.; Hangoc, G.; Oliff, A.; Chen, L.T.; Shen, R.N.; Broxmeyer, H.E. Protective influence of lactoferrin on mice infected with the polycythemia-inducing strain of Friend virus complex. Cancer Res. 1987, 47, 4184-4188. (Pubitemid 17108491)
55. Hasegawa, K.; Motsuchi, W.; Tanaka, S.; Dosako, S. Inhibition with lactoferrin of in vitro infection with human herpes virus. Jpn. J. Med. Sci. Biol. 1994, 47, 73-85. (Pubitemid 24333771)
56. Superti, F.; Berlutti, F.; Paesano, R.; Valenti, P. Structure and activity of lactoferrin\-A multi functional protective agent for human health. In Iron Metabolism and Disease; Fuchs, H., Ed.; Research Signpost: Kerala, India, 2008; pp. 1-32.
57. Andersen, J.H.; Osbakk, S.A.; Vorland, L.H.; Traavik, T.; Gutteberg, T.J. Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts. Antiviral Res. 2001, 51, 141-149. (Pubitemid 32592502)
58. Harmsen, M.C.; Swart, P.J.; de Bethune, M.P.; Pauwels, R.; De Clercq, E.; The, T.H.; Meijer, D.K. Antiviral effects of plasma and milk proteins: Lactoferrin shows a potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. J. Infect. Dis. 1995, 172, 380-388.
59. Beljaars, L.; van der Strate, B.W.; Bakker, H.I.; Reker-Smit, C.; van Loenen-Weemaes, A.M.; Wiegmans, F.C.; Harmsen, M.C.; Molema, G.; Meijer, D.K. Inhibition of cytomegalovirus infection by lactoferrin in vitro and in vivo. Antiviral Res. 2004, 63, 197-208. (Pubitemid 39286757)
60. Marchetti, M.; Longhi, C.; Conte, M.P.; Pisani, S.; Valenti, P.; Seganti, L. Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells. Antiviral Res. 1996, 29, 221-231. (Pubitemid 26135179)
61. Marchetti, M.; Pisani, S.; Antonini, G.; Valenti, P.; Seganti, L.; Orsi, N. Metal complexes of bovine lactoferrin inhibit in vitro replication of herpes simplex virus type 1 and 2. Biometals 1998, 11, 89-94. (Pubitemid 28140327)
62. Siciliano, R.; Rega, B.; Marchetti, M.; Seganti, L.; Antonini, G.; Valenti, P. Bovine lactoferrin peptidic fragments involved in inhibition of herpes simplex virus type-1 infection. Biochem. Biophys. Res. Commun. 1999, 264, 19-23. (Pubitemid 29500456)
63. Valenti, P.; Antonini, G.; Siciliano, R.; Rega, B.; Superti, F.; Marchetti, M.; Ammendolia, M.G.; Seganti, L. Antiviral activity of lactoferrin-derived peptides. In Lactoferrin: Structure, Function, and Applications; Shimazaki, K., Tsuda, H., Tomita, M., Kuwata, T., Perraudin, J.P., Eds.; Elsevier Science Ltd: Tokyo, Japan, 2000; pp. 181-186.
64. Seganti, L.; Di Biase, A.M.; Rega, B.; De Giulio, B.; Nicoletti, M.; Antonini, G.; Valenti, P. Involvement of bovine lactoferrin moieties in the inhibition of herpes simplex virus type 1 infection. Int. J. Immunopathol. Pharmacol. 2001, 14, 71-79. (Pubitemid 32744445)
65. Shukla, D.; Spear, P.G. Herpesviruses and heparan sulfate: An intimate relationship in aid of viral entry. J. Clin. Invest. 2001, 108, 503-510. (Pubitemid 32777727)
66. Marchetti, M.; Trybala, E.; Superti, F.; Johansson, M.; Bergstrom, T. Inhibition of herpes simplex virus infection by lactoferrin is dependent on interference with the virus binding to glycosaminoglycans. Virology 2004, 318, 405-413. (Pubitemid 38236170)
67. Marchetti, M.; Ammendolia, M.G.; Superti, F. Glycosaminoglycans are not indispensabile for the anti-herpes simplex virus type 2 activity of lactoferrin. Biochemistry 2009, 91, 155-159.
68. Välimaa, H.; Tenovuo, J.; Waris, M.; Hukkanen, V. Human lactoferrin but not lysozyme neutralizes HSV-1 and inhibits HSV-1 replication and cell-to-cell spread. J. Virol. 2009, 6, 53.
69. Andersen, J.H.; Jenssen, H.; Gutteberg, T.J. Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir. Antiviral Res. 2003, 58, 209-215. (Pubitemid 36589011)
70. Anderssen, J.H.; Jenssen, H.; Sandvik, K.; Gutteberg, T.J. Anti-HSV activity of lactoferrin and lactoferricin is dependent on the presence of heparan sulphate at the cell surface. J. Med. Virol. 2004, 74, 262-271. (Pubitemid 39150393)
71. Jenssen, H.; Anderssen, J.H.; Uhlin-Hanssen, L.; Gutteberg, T.J.; Rekdal, O. Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate. Antiviral Res. 2004, 61, 101-109. (Pubitemid 37506097)
72. Jenssen, H.; Sandvik, K.; Andersen, J.H.; Hancock, R.E.W.; Gutteberg, T.J. Inhibition of HSV cell-to-cell spread by lactoferrin and lactoferricin. Antiviral Res. 2008, 79, 192-198.
73. Ammendolia, M.G.; Pietrantoni, A.; Tinari, A.; Valenti, P.; Superti, F. Bovine lactoferrin inhibits echovirus endocytic pathway by interacting with viral structural polypeptides. Antiviral Res. 2007, 73, 151-160.
74. Marr, A.K.; Jenssen, H.; Moniri, M.R.; Hancock, R.E.W.; Panté, N. Bovine lactoferrin and lactoferricin interfere with intracellular trafficking of Herpes simplex virus-1. Biochemistry 2009, 91, 160-164.
75. Shimizu, K.; Matsuzawa, H.; Okada, K.; Tazume, S.; Dosako, S.; Kawasaki, Y.; Hashimoto, K.; Koga, Y. Lactoferrin-mediated protection of the host from murine cytomegalovirus infection by a T-cell dependent augmentation of natural killer cell activity. Arch. Virol. 1996, 141, 1875-1889. (Pubitemid 26392962)
76. Fujihara, T.; Hayashi, K. Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection in mouse cornea. Arch. Virol. 1995, 140, 1469-1472.
77. Wakabayashi, H.; Kurokawa, M.; Shin, K.; Teraguchi, S.; Tamura, Y.; Shiraki, K. Oral lactoferrin prevents body weight loss and increases cytokine responses during herpes simplex virus type 1 infection of mice. Biosci. Biotechnol. Biochem. 2004, 68, 537-544. (Pubitemid 39251489)
78. Shust, G.F.; Cho, S.; Kim, M.; Madan, R.P.; Guzman, E.M.; Pollack, M.; Epstein, J.; Cohen, H.W.; Keller, M.J.; Herold, B.C. Female genital tract secretions inhibit herpes simplex virus infection: Correlation with soluble mucosal immune mediators and impact of hormonal contraception. Am. J. Reprod. Immunol. 2010, 63, 110-119.
79. Beaumont, S.L.; Maggs, D.J.; Clarke, H.E. Effects of bovine lactoferrin on in vitro replication of feline herpesvirus. Vet. Ophthalmol. 2003, 6, 245-250. (Pubitemid 37237430)
80. Tanaka, T.; Nakatani, S.; Xuan, X.; Kumura, H.; Igarashi, I.; Shimazaki, K. Antiviral activity of lactoferrin against canine herpesvirus. Antiviral Res. 2003, 60, 193-199. (Pubitemid 37456867)
81. Swart, P.J.; Harmsen, M.C.; Kuipers, M.E.; Van Dijk, A.A.; Van Der Strate, B.W.; Van Berkel, P.H.; Nuijens, J.H.; Smit, C.; Witvrouw, M.; De Clercq, E.; et al. Charge modification of plasma and milk proteins results in antiviral active compounds. J. Pept. Sci. 1999, 5, 563-576. (Pubitemid 30019138)
82. Swart, P.J.; Kuipers, M.E.; Smith, C.; Pawels, R.; De Bethune, M.P.; De Clerck, E.; Meijer, D.K.; Huisman, J.G. Antiviral effects of milk proteins: Acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro. AIDS Res. Hum. Retroviruses 1996, 12, 769-775. (Pubitemid 26171118)
83. Puddu, P.; Borghi, P.; Gessani, S.; Valenti, P.; Belardelli, F.; Seganti, L. Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection. Int. J. Biochem. Cell Biol. 1998, 30, 1055-1062.
84. Ng, T.B.; Lam, T.L.; Au, T.K.; Ye, X.Y.; Wan, C.C. Inhibition of human immunodeficiency virus type 1 reverse transcriptase, protease and integrase by bovine milk proteins. Life Sci. 2001, 69, 2217-2223. (Pubitemid 32907566)
85. Berkhout, B.; van Wamel, J.L.; Beljaars, L.; Meijer, D.K.; Visser, S.; Floris, R. Characterization of the anti-HIV effects of native lactoferrin and other milk proteins and protein-derived peptides. Antiviral Res. 2002, 55, 341-355. (Pubitemid 34718133)
86. Groot, F.; Geijtenbeek, T.B.; Sanders, R.W.; Baldwin, C.E.; Sanchez-Hernandez, M.; Floris, R.; van Kooyk, Y.; de JonG, E.C.; Berkhout, B. Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN\-gp120 interaction. J. Virol. 2005, 79, 3009-3015. (Pubitemid 40270580)
87. Viani, R.M.; Gutteberg, T.J.; Lathey, J.L.; Spector, S.A. Lactoferrin inhibits HIV-1 replication in vitro and exhibits synergy when combined with zidovudine. AIDS 1999, 13, 1273-1274. (Pubitemid 29361099)
88. Kobayashi, S.; Sato, R.; Aoki, T.; Omoe, K.; Inanami, O.; Hankanga, C.; Yamada, Y.; Tomizawa, N.; Yasuda, J.; Sasaki, J. Effect of bovine lactoferrin on functions of activated feline peripheral blood mononuclear cells during chronic feline immunodeficiency virus infection. J. Vet. Med. Sci. 2008, 70, 429-435. (Pubitemid 351798923)
89. Chen, L.T.; Lu, L.; Broxmeyer, H.E. Effects of purified iron-saturated human lactoferrin on spleen morphology in mice infected with Friend virus complex. Am. J. Pathol. 1987, 126, 285-292. (Pubitemid 17033853)
90. Lu, L.; Shen, R.N.; Zhou, S.Z.; Srivastava, C.; Harrington, M.; Miyazawa, K.; Wu, B.; Lin, Z.H.; Ruscetti, S.; Broxmeyer, H.E. Synergistic effect of human lactoferrin and recombinant murine interferon-gamma on disease progression in mice infected with the polycythemia-inducing strain of the Friend virus complex. Int. J. Hematol. 1991, 54, 117-124.
91. Yi, M.; Kaneko, S.; Yu, D.Y.; Murakami, S. Hepatitis C virus envelope proteins bind lactoferrin. J. Virol. 1997, 71, 5997-6002. (Pubitemid 27304937)
92. Ikeda, M.; Sugiyama, K.; Tanaka, T.; Tanaka, K.; Sekihara, H.; Shimotohno, K.; Kato, N. Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes. Biochem. Biophys. Res. Commun. 1998, 245, 549-553. (Pubitemid 28418543)
93. Ikeda, M.; Nozaki, A.; Sugiyama, K., Tanaka, T.; Naganuma, A.; Tanaka, K.; Sekihara, H.; Shimotohno, K.; Saito, M.; Kato, N. Characterization of antiviral activity of lactoferrin against hepatitis C virus infection in human cultured cells. Virus Res. 2000, 66, 51-63. (Pubitemid 30069804)
94. Nozaki, A.; Ikeda, M.; Naganuma, A.; Nakamura, T.; Inudoh, M.; Tanaka, K.; Kato, N. Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein. J. Biol. Chem. 2003, 278, 10162-10173. (Pubitemid 36800275)
95. Abe, K.; Nozaki, A.; Tamura, K.; Ikeda, M.; Naka, K.; Dansako, H.; Hoshino, H.O.; Tanaka, K.; Kato, N. Tandem repeats of lactoferrin-derived anti-hepatitis C virus peptide enhance antiviral activity in cultured human hepatocytes. Microbiol. Immunol. 2007, 51, 117-125. (Pubitemid 46155194)
96. Beleid, R.; Douglas, D.; Kneteman, N.; Kaur, K. Helical Peptides Derived from Lactoferrin Bind Hepatitis C Virus Envelope Protein E2. Chem. Biol. Drug Des. 2008, 72, 436-443.
97. Tanaka, K.; Ikeda, M.; Nozaki, A.; Kato, N.; Tsuda, H.; Saito, S.; Sekihara, H. Lactoferrin inhibits hepatitis C virus viremia in patients with chronic hepatitis C: A pilot study. Jpn J. CancerRes. 1999, 90, 367-371. (Pubitemid 29213539)
98. Okada, S.; Tanaka, K.; Sato, T.; Ueno, H.; Saito, S.; Okusaka, T.; Sato, K.; Yamamoto, S.; Kakizoe, T. Dose-response trial of lactoferrin in patients with chronic hepatitis C. Jpn J. Cancer Res. 2002, 93, 1063-1069. (Pubitemid 35154274)
99. Ishii, K.; Takamura, N.; Shinohara, M.; Wakui, N.; Shin, H.; Sumino, Y.; Ohmoto, Y.; Teraguchi, S.; Yamauchi, K. Long-term follow-up of chronic hepatitis C patients treated with oral lactoferrin for 12 months. Hepatol. Res. 2003, 25, 226-233. (Pubitemid 36546348)
100. Amati, L.; Cozzolongo, R.; Manghisi, O.G.; Cuppone, R.; Pellegrino, N.M.; Caccavo, D.; Birillo, E. The immune responsiveness in hepatitis C virus infected patients: Effects of interferon alfa/ribavirin combined treatment on the lymphocyte response with special reference to B cells. Curr. Pharm. Des. 2004, 36, 2093-2100. (Pubitemid 38842653)
101. Caradonna, L.; Mastronardi, M.L.; Magrone, T.; Cozzolongo, R.; Cuppone, R.; Manghis, O.G.; Caccavo, D.; Pellegrino, N.M.; Amoroso, A.; Jirillo, E.; Amati, L. Biological and clinical significance of endotoxemia in the course of hepatitis C virus infection. Curr. Pharm. Des. 2002, 8, 995-1005. (Pubitemid 34506400)
102. Ueno, H.; Sato, T.; Yamamoto, S.; Tanaka, K.; Ohkawa, S.; Takagi, H.; Yokosuka, O.; Furuse, J.; Saito, H.; Sawaki, A.; et al. Randomized, double-blind, placebo-controlled trial of bovine lactoferrin in patients with chronic hepatitis C. Cancer Sci. 2006, 97, 1105-1110. (Pubitemid 44322561)
103. Kaito, M.; Iwasa, M.; Fujita, N.; Kobayashi, Y.; Kojima, Y.; Ikoma, J.; Imoto, I.; Adachi, Y.; Hamano, H.; Yamauchi, K. Effect of lactoferrin in patients with chronic hepatitis C: Combination therapy with interferon and ribavirin. J. Gastroenterol. Hepatol. 2007, 22, 1894-1897 (Pubitemid 47525086)
104. Redwan, el-RM Tabll, A. Camel lactoferrin markedly inhibits hepatitis C virus genotype 4 infection of human peripheral blood leukocytes. J. Immunoassay Immunochem. 2007, 28, 267-277.
105. Hara, K.; Ikeda, M.; Saito, S.; Matsumoto, S.; Numata, K.; Kato, N.; Tanaka, K.; Sekihara, H. Lactoferrin inhibits hepatitis B virus infection in cultured human hepatocytes. Res. Hepatol. 2002, 24, 228-235. (Pubitemid 35314579)
106. Li, S.; Zhou, H.; Huang, G.; Liu, N. Inhibition of HBV infection by bovine lactoferrin and iron zinc-saturated lactoferrin. Med. Microbiol. Immunol. 2009, 198, 19-25.
107. Petrova, M.; Kamburov, V. Breastfeeding and chronic HBV infection: Clinical and social implications. World J. Gastroenterol. 2010, 16, 5042-5046.
108. Portelli, J.; Gordon, A.; May, J.T. Effect of compounds with antibacterial activities in human milk on respiratory syncytial virus and citomegalovirus in vitro. J. Med. Microbiol. 1998, 47, 1015-1018. (Pubitemid 28499864)
109. Sano, H.; Nagai, K.; Tsutsumi, H.; Kuroki, Y. Lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infection. Eur. J. Immunol. 2003, 33, 2894-2902. (Pubitemid 37337155)
110. Yamamoto, H.; Ura, Y., Tanemura, M.; Koyama, A.; Takano, S.; Uematsu, J.; Kawano, M.; Tsurudome, M.; O'Brien, M.; Komada, H. Inhibitory effect of bovine lactoferrin on human parainfluenza virus type 2 infection. J. Health Sci. 2010, 54, 613-617.
111. Waarts, B.L.; Aneke, O.J.; Smit, J.M.; Kimata, K.; Bittman, R.; Meijer, D.K.; Wilschut, J. Antiviral activity of human lactoferrin: Inhibition of alphavirus interaction with heparan sulfate. Virology 2005, 333, 284-292. (Pubitemid 40250112)
112. Murphy, M.E.; Kariwa, H.; Mizutani, T.; Yoshimatsu, K.; Arikawa, J.; Takashima, I. In vitro antiviral activity of lactoferrin and ribavirin upon hantavirus. Arch. Virol. 2000, 145, 1571-1582.
113. Hardestam, J.; Petterson, L.; Ahlm, C.; Evander, M.; Lundkvist, A.; Klingström, J. Effect of Human Saliva Against Hantavirus. J. Med. Virol. 2008, 80, 2122-2126.
114. Murphy, M.E.; Kariwa, H.; Mizutani, T.; Tanabe, H.; Yoshimatsu, K.; Arikawa, J.; Takashima, I. Characterization of in vitro and in vivo antiviral activity of lactoferrin and ribavirin upon hantavirus. J. Vet. Med. Sci. 2001, 63, 637-645. (Pubitemid 33641625)
115. Drobni, P.; Naslund, J.; Evander, M. Lactoferrin inhibits human papilloma virus binding and uptake in vitro. Antiviral Res. 2004, 64, 63-68. (Pubitemid 39286749)
116. Mistry, N.; Drobni, P.; Naslund, J.; Sunkari, V.G.; Jenssen, H.; Evander, M. The anti papillomavirus activity of human and bovine lactoferricin. Antiviral Res. 2007, 75, 258-265. (Pubitemid 46898653)
117. Degener, A.M.; Longhi, G.; Mischitelli, M.; Longhi, C.; Conte, M.P.; Valenti, P.; Seganti, L.; Marchetti, M.; Superti, F. Lactoferrin inhibits human BK polyomavirus adsorption to Vero cells. Biochem. Cell Biol. 2006, 84, 389-389.
118. Superti, F.; Ammendolia, M.G.; Valenti, P.; Seganti, L. Antirotaviral activity of milk proteins: Lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29. Med. Microbiol. Immunol. 1997, 186, 83-91. (Pubitemid 27477875)
119. Superti, F.; Siciliano, R.; Rega, B.; Giansanti, F.; Valenti, P.; Antonini, G. Involvement of bovine lactoferrin metal saturation, sialic acid and protein fragments in the inhibition of rotavirus infection. Biochim. Biophys. Acta 2001, 1528, 107-115. (Pubitemid 33001271)
120. Superti, F.; Donelli, G. Characterization of SA-11 rotavirus receptorial structures on human colon carcinoma cell line HT-29. J. Med. Virol. 1995, 47, 421-428. (Pubitemid 26018998)
121. Perez-Cano, F.J.; Marn-Gallen, S.; Castell, M.; Rodrguez-Palmero, M.; Rivero, M.; Castellote, C.; Franch, A. Supplementing suckling rats with whey protein concentrate modulates the immune response and ameliorates rat rotavirus-induced diarrhea. J. Nutr. 2008, 138, 2392-2398.
122. McCann, K.B.; Lee, A.; Wan, J.; Roginski, H.; Coventry, M.J. The effect of bovine lactoferrin and lactoferricin B on the ability of feline calicivirus (a norovirus surrogate) and poliovirus to infect cell cultures. J. Appl. Microbiol. 2003, 95, 1026-1033. (Pubitemid 37357385)
123. Pan, Y.; Rowney, M.; Guo, P.; Hobman, P. Biological properties of lactoferrin: An overview. Aust. J. Dairy Technol. 2007, 62, 31-42. (Pubitemid 46833700)
124. Arnold, D.; Di Biase, A.M.; Marchetti, M.; Pietrantoni, A.; Valenti, P.; Seganti, L.; Superti, F. Antiadenovirus activity of milk proteins: Lactoferrin prevents viral infection. Antiviral Res. 2002, 53, 153-158. (Pubitemid 34062835)
125. Marchetti, M.; Superti, F.; Ammendolia, M.G.; Rossi, P.; Valenti, P.; Seganti, L. Inhibition of poliovirus type 1 infection by iron-, manganese- and zinc-saturated lactoferrin. Med. Microbiol. Immunol. 1999, 187, 199-204. (Pubitemid 29216755)
126. Di Biase, AM.; Pietrantoni, A.; Tinari, A.; Siciliano, R.; Valenti, P.; Antonimi, G.; Seganti, L.; Superti, F. Heparin-interacting sites of bovine lactoferrin are involved in anti-adenovirus activity. J. Med. Virol. 2003, 69, 495-502. (Pubitemid 36249863)
127. Dechecchi, M.C.; Tamanini, A.; Bonizzato, A.; Cabrini, G. Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions. Virology 2000, 268, 382-390. (Pubitemid 30159987)
128. Pietrantoni, A.; Di Biase, A.M.; Tinari, A.; Marchetti, M.; Valenti, P.; Seganti, L.; Superti, F. Bovine lactoferrin inhibits adenovirus infection by interacting with viral structural polypeptides. Antimicrob. Agents Chemother. 2003, 47, 2688-2691. (Pubitemid 36919483)
129. Bergelson, J.M.; Cunningham, J.A.; Droguett, G.; Kurt-Jones, E.A.; Krithivas, A.; Hong, J.S.; Horwitz, M.S.; Crowell, R.L.; Finberg, R.W. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science 1997, 275, 1320-1323. (Pubitemid 27114163)
130. Roelvink, P.W.; Lizonova, A.; Lee, J.G.; Li, Y.; Bergelson, J.M.; Finberg, R.W.; Brough, D.E.; Kovesdi, I.; Wickham, T.J. The coxsackievirus- adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F. J. Virol. 1998, 72, 7909-7915.
131. Tomko, R.P.; Xu, R.; Philipson, L. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses. Proc. Natl. Acad. Sci. USA 1997, 94, 3352-3356. (Pubitemid 27157315)
132. Roelvink, P.W.; Kovesdi, I.; Wickham, T.J. Comparative analysis of adenovirus fiber-cell interaction: Adenovirus type 2 (Ad2) and Ad9 utilize the same cellular fiber receptor but use different binding strategies for attachment. J. Virol. 1996, 70, 7614-7621. (Pubitemid 26339066)
133. Wickham, T.J.; Mathias, P.; Cheresh, D.A.; Nemerow, G.R. Integrins avb3 and avb5 promote adenovirus internalization but not virus attachment. Cell 1993, 73, 309-319.
134. Günther, P.S.; Mikeler, E.; Hamprecht, K.; Schneider-Schaulies, J.; Jahn, Gerhard; Dennehy, K.M. CD209/DC-SIGN mediates efficient infection of monocyte derived dendritic cells by clinical adenovirus 2C isolates in the presence of bovine lactoferrin. J. Gen. Virol. 2011, in Press.
135. Ford, E.; Nelson, K.E.; Warren, D. Epidemiology of epidemic keratoconjunctivitis. Epidemiol. Rev. 1987, 9, 244-261.
136. Kijlstra, A.; Jeurissen, S.H.; Koning, K.M. Lactoferrin levels in normal human tears. Br. J. Ophthalmol. 1983, 67, 199-202. (Pubitemid 13144022)
137. Flanagan, J.L. Role of lactoferrin in the tear film. Biochimie 2009, 91, 35-43.
138. Johansson, C.; Jonsson, M.; Marttila, M.; Persson, D.; Fan, X.L.; Skog, J.; Frängsmyr, L.; Wadell, G.; Arnberg, N. Adenoviruses use lactoferrin as a bridge for CAR-independent binding to and infection of epithelial cells. J. Virol. 2007, 81, 954-963. (Pubitemid 46067920)
139. Adams, W.C.; Bond, E.; Havenga, M.J.; Holterman, L.; Goudsmit, J.; Karlsson Hedestam, G.B.; Koup, R.A.; Loré, K. Adenovirus serotype 5 infects human dendritic cells via a coxsackievirus-adenovirus receptor-independent receptor pathway mediated by lactoferrin and DC-SIGN. J. Gen. Virol. 2009, 90, 1600-1610.
140. Sanchez, L.; Ismail, M.; Liew, F.Y.; Brock, J.H. Iron transport across Caco-2 cell monolayers. Effect of transferrin, lactoferrin and nitric oxide. Biochim. Biophys. Acta 1996, 1289, 291-297. (Pubitemid 26088686)
141. Rangel, L.M.; Fernandez-Tomas, C.; Dahmus, M.E.; Gariglio, P. Poliovirus-induced modification of host cell RNA polymerase IIO is prevented by cycloheximide and zinc. J. Biol. Chem. 1988, 263, 19267-19269. (Pubitemid 19016399)
142. Ratka, M.; Lackmann, M.; Ueckermann, C.; Karlins, U.; Koch, G. Poliovirus-associated protein kinase: Destabilization of the virus capsid and stimulation of the phosphorylation reaction by Zn2+. J. Virol. 1989, 63, 3954-3960. (Pubitemid 19205471)
143. Lin, T.Y.; Chu, C.; Chiu, C.H. Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro. J. Infect. Dis. 2002, 186, 1161-1164. (Pubitemid 35177120)
144. Chen, H.L.; Wang, L.C.; Chang, C.H.; Yen, C.C.; Cheng, W.T.K.; Wu, S.C.; Hung, C.M.; Kuo, M.F.; Chen, C.M. Recombinant porcine lactoferrin expressed in the milk of transgenic mice protects neonatal mice from a lethal challenge with enterovirus type 71. Vaccine 2008, 26, 891-898.
145. Tinari, A.; Pietrantoni, A.; Ammendolia, M.G.; Valenti, P.; Superti, F. Inhibitory activity of bovine lactoferrin against echovirus induced programmed cell death in vitro. Int. J. Antimicrob. Agents 2005, 25, 433-438. (Pubitemid 40558777)
146. Ammendolia, M.G.; Pietrantoni, A.; Tinari, A.; Valenti, P.; Superti, F. Bovine lactoferrin inhibits echovirus endocytic pathway by interacting with viral structural polypeptides. Antiviral Res. 2007, 73, 151-160.
147. Clarke, N.M.; May, J.T. Effect of antimicrobial factors in human milk on rhinoviruses and milk borne cytomegalovirus in vitro. J. Med. Microbiol. 2000, 49, 719-723. (Pubitemid 30623904)
148. Pietrantoni, A.; Dofrelli, E.; Tinari, A.; Ammendolia, M.G.; Puzelli, S.; Fabiani, C.; Donatelli, I.; Superti, F. Bovine lactoferrin inhibits Influenza A virus induced programmed cell death in vitro. Biometals 2010, 23, 465-475.
149. Taha, S.H.; Mehrez, M.A.; Sitohy, M.Z.; Abou Dawood, A.G.; Abd-El Hamid, M.M.; Kilany, W.H. Effectiveness of esterified whey proteins fractions against Egyptian Lethal Avian Influenza A (H5N1). J. Virol. 2010, 7, 330-333.
150. Chien, Y.J.; Chen, W.J.; Hsu, W.L.; Chiou, S.S. Bovine lactoferrin inhibits Japanese encephalitis virus by binding to heparan sulfate and receptor for low density lipoprotein. Virology 2008, 379, 143-151.
151. Abdelbacki, A.M.; Taha, S.H.; Sitohy, M.Z.; Abou Dawood, A.I.; Abd-El Hamid, M.M.; Rezk, A.A. Inhibition of tomato yellow leaf curl virus (TYLCV) using whey proteins. Virol. J. 2010, 3, 7-26.
152. Osterlund, P.J.; Pirhonen, N.; Ikonen, E.; Ronkko, M.; Strengell, S.M.; Makela, M.; Broman, O.J.; Hamming, R.; Hartmann, T.; Ziegler, T.; Julkunen, I. Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons. J. Virol. 2010, 84, 1414-1422.